Nascent endothelium initiates Th2 polarization of asthma

Journal of Immunology

Volumn 190, Issue 7, 2013, Pages 3458-3465

  Asosingh, Kewal ^a   Cheng, Georgiana ^a   Xu, Weiling ^a   Savasky, Benjamin M ^a   Aronica, Mark A ^a   Li, Xiaoxia ^a   Erzurum, Serpil C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; E4G10 ANTIBODY; IMMUNOGLOBULIN E; INTERLEUKIN 25; THYMIC STROMAL LYMPHOPOIETIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; ASTHMA; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; EOSINOPHIL; FEMALE; IMMUNOGLOBULIN PRODUCTION; LUNG FIBROSIS; METAPLASIA; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RESPIRATORY TRACT ALLERGY; TH2 CELL; VASCULAR ENDOTHELIUM;

AIRWAY REMODELING; ALLERGENS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ASTHMA; BONE MARROW CELLS; CADHERINS; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENDOTHELIUM; FEMALE; HEMATOPOIETIC STEM CELLS; IMMUNOGLOBULIN E; INTERLEUKINS; LUNG; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; STAT6 TRANSCRIPTION FACTOR; TH2 CELLS;

EID: 84875476748     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202095     Document Type: Article

References (50)

1. Akimoto, T., F. Numata, M. Tamura, Y. Takata, N. Higashida, T. Takashi, K. Takeda, and S. Akira. 1998. Abrogation of bronchial eosinophilic inflammation nd airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice. J. Exp. Med. 187: 1537-1542.
2. Al-Shami, A., R. Spolski, J. Kelly, A. Keane-Myers, and W. J. Leonard. 2005. A role for TSLP in the development of inflammation in an asthma model. J. Exp. Med. 202: 829-839.
3. Soumelis, V., P. A. Reche, H. Kanzler, W. Yuan, G. Edward, B. Homey, M. Gilliet, S. Ho, S. Antonenko, A. Lauerma, et al. 2002. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 3: 673-680.
4. Zhou, B., M. B. Headley, T. Aye, J. Tocker, M. R. Comeau, and S. F. Ziegler. 2008. Reversal of thymic stromal lymphopoietin-induced airway inflammation through inhibition of Th2 responses. J. Immunol. 181: 6557-6562.
5. Angkasekwinai, P., H. Park, Y. H. Wang, Y. H. Wang, S. H. Chang, D. B. Corry, Y. J. Liu, Z. Zhu, and C. Dong. 2007. Interleukin 25 promotes the initiation of proallergic type 2 responses. J. Exp. Med. 204: 1509-1517.
6. Fort, M. M., J. Cheung, D. Yen, J. Li, S. M. Zurawski, S. Lo, S. Menon, T. Clifford, B. Hunte, R. Lesley, et al. 2001. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15: 985-995.
7. Dunnill, M. S. 1960. The pathology of asthma, with special reference to changes in the bronchial mucosa. J. Clin. Pathol. 13: 27-33.
8. Zimmermann, N., A. Mishra, N. E. King, P. C. Fulkerson, M. P. Doepker, N. M. Nikolaidis, L. E. Kindinger, E. A. Moulton, B. J. Aronow, and M. E. Rothenberg. 2004. Transcript signatures in experimental asthma: identification of STAT6-dependent and -independent pathways. J. Immunol. 172: 1815-1824.
9. Locksley, R. M. 2010. Asthma and allergic inflammation. Cell 140: 777-783.
10. Cunningham, A. C., J. G. Zhang, J. V. Moy, S. Ali, and J. A. Kirby. 1997. A comparison of the antigen-presenting capabilities of class II MHC-expressing human lung epithelial and endothelial cells. Immunology 91: 458-463.
11. Ellis, A. 1908. The pathological anatomy of bronchial asthma. Am. J. Med. Sci. 1906: 407-428.
12. Asosingh, K., S. Swaidani, M. Aronica, and S. C. Erzurum. 2007. Th1- and Th2-dependent endothelial progenitor cell recruitment and angiogenic switch in asthma. J. Immunol. 178: 6482-6494.
13. Corrigan, C. J., W. Wang, Q. Meng, C. Fang, H. Wu, V. Reay, Z. Lv, Y. Fan, Y. An, Y. H. Wang, et al. 2011. T-helper cell type 2 (Th2) memory T cellpotentiating cytokine IL-25 has the potential to promote angiogenesis in asthma. Proc. Natl. Acad. Sci. USA 108: 1579-1584.
14. Shaked, Y., F. Bertolini, S. Man, M. S. Rogers, D. Cervi, T. Foutz, K. Rawn, D. Voskas, D. J. Dumont, Y. Ben-David, et al. 2005. Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis: Implications for cellular surrogate marker analysis of antiangiogenesis. Cancer Cell 7: 101-111.
15. Asosingh, K., J. D. Hanson, G. Cheng, M. A. Aronica, and S. C. Erzurum. 2010. Allergen-induced, eotaxin-rich, proangiogenic bone marrow progenitors: a bloodborne cellular envoy for lung eosinophilia. J. Allergy Clin. Immunol. 125: 918-925.
16. Carmeliet, P., M. G. Lampugnani, L. Moons, F. Breviario, V. Compernolle, F. Bono, G. Balconi, R. Spagnuolo, B. Oosthuyse, M. Dewerchin, et al. 1999. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98: 147-157.
17. Crosby, C. V., P. A. Fleming, W. S. Argraves, M. Corada, L. Zanetta, E. Dejana, and C. J. Drake. 2005. VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood 105: 2771-2776.
18. Liao, F., J. F. Doody, J. Overholser, B. Finnerty, R. Bassi, Y. Wu, E. Dejana, P. Kussie, P. Bohlen, and D. J. Hicklin. 2002. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Cancer Res. 62: 2567-2575.
19. May, C., J. F. Doody, R. Abdullah, P. Balderes, X. Xu, C. P. Chen, Z. Zhu, L. Shapiro, P. Kussie, D. J. Hicklin, et al. 2005. Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature. Blood 105: 4337-4344.
20. Gao, D., D. J. Nolan, A. S. Mellick, K. Bambino, K. McDonnell, and V. Mittal. 2008. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319: 195-198.
21. Aronica, M. A., S. McCarthy, S. Swaidani, D. Mitchell, M. Goral, J. R. Sheller, and M. Boothby. 2004. Recall helper T cell response: T helper 1 cell-resistant allergic susceptibility without biasing uncommitted CD4 T cells. Am. J. Respir. Crit. Care Med. 169: 587-595.
22. Aronica, M. A., S. Swaidani, Y. H. Zhang, D. Mitchell, A. L. Mora, S. McCarthy, J. O'Neal, D. Topham, J. R. Sheller, and M. Boothby. 2004. Susceptibility to allergic lung disease regulated by recall responses of dual-receptor memory T cells. J. Allergy Clin. Immunol. 114: 1441-1448.
23. Jonasson, S., G. Hedenstierna, H. Hedenström, and J. Hjoberg. 2009. Comparisons of effects of intravenous and inhaled methacholine on airway physiology in a murine asthma model. Respir. Physiol. Neurobiol. 165: 229-236.
24. Debeer, A., A. W. Flemmer, P. J. Lewi, S. Beheydt, F. De Buck, L. J. Zimmermann, G. Naulaers, and J. A. Deprest. 2010. Preterm rabbit lung tissue mechanics: maturational changes and effect of antenatal steroids. Pediatr. Pulmonol. 45: 349-355.
25. Fulkerson, P. C., C. A. Fischetti, M. L. McBride, L. M. Hassman, S. P. Hogan, and M. E. Rothenberg. 2006. A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation. Proc. Natl. Acad. Sci. USA 103: 16418-16423.
26. Fulkerson, P. C., C. A. Fischetti, and M. E. Rothenberg. 2006. Eosinophils and CCR3 regulate interleukin-13 transgene-induced pulmonary remodeling. Am. J. Pathol. 169: 2117-2126.
27. Pope, S. M., P. C. Fulkerson, C. Blanchard, H. S. Akei, N. M. Nikolaidis, N. Zimmermann, J. D. Molkentin, and M. E. Rothenberg. 2005. Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation. J. Biol. Chem. 280: 13952-13961.
28. Urbich, C., and S. Dimmeler. 2004. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95: 343-353.
29. Urbich, C., C. Heeschen, A. Aicher, E. Dernbach, A. M. Zeiher, andS. Dimmeler. 2003. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108: 2511-2516.
30. Chavakis, E., A. Aicher, C. Heeschen, K. Sasaki, R. Kaiser, N. El Makhfi, C. Urbich, T. Peters, K. Scharffetter-Kochanek, A. M. Zeiher, et al. 2005. Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J. Exp. Med. 201: 63-72.
31. Rössig, L., C. Urbich, T. Brühl, E. Dernbach, C. Heeschen, E. Chavakis, K. Sasaki, D. Aicher, F. Diehl, F. Seeger, et al. 2005. Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells. J. Exp. Med. 201: 1825-1835.
32. Xu, W., S. A. Comhair, S. Zheng, S. C. Chu, J. Marks-Konczalik, J. Moss, S. J. Haque, and S. C. Erzurum. 2003. STAT-1 and c-Fos interaction in nitric oxide synthase-2 gene activation. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L137-L148.
33. Sharma, P., R. Chakraborty, L. Wang, B. Min, M. L. Tremblay, T. Kawahara, J. D. Lambeth, and S. J. Haque. 2008. Redox regulation of interleukin-4 signaling. Immunity 29: 551-564.
34. Jackson, J. R., M. P. Seed, C. H. Kircher, D. A. Willoughby, and J. D. Winkler. 1997. The codependence of angiogenesis and chronic inflammation. FASEB J. 11: 457-465.
35. Carmeliet, P., V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, M. Gertsenstein, M. Fahrig, A. Vandenhoeck, K. Harpal, C. Eberhardt, et al. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439.
36. Ferrara, N., K. Carver-Moore, H. Chen, M. Dowd, L. Lu, K. S. O'Shea, L. Powell-Braxton, K. J. Hillan, and M. W. Moore. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442.
37. Lee, C. G., H. Link, P. Baluk, R. J. Homer, S. Chapoval, V. Bhandari, M. J. Kang, L. Cohn, Y. K. Kim, D. M. McDonald, and J. A. Elias. 2004. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat. Med. 10: 1095-1103.
38. Carmeliet, P. 2003. Angiogenesis in health and disease. Nat. Med. 9: 653-660.
39. Carmeliet, P., and R. K. Jain. 2000. Angiogenesis in cancer and other diseases. Nature 407: 249-257.
40. Corada, M., M. Mariotti, G. Thurston, K. Smith, R. Kunkel, M. Brockhaus, M. G. Lampugnani, I. Martin-Padura, A. Stoppacciaro, L. Ruco, et al. 1999. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc. Natl. Acad. Sci. USA 96: 9815-9820.
41. Ying, S., B. O'Connor, J. Ratoff, Q. Meng, K. Mallett, D. Cousins, D. Robinson, G. Zhang, J. Zhao, T. H. Lee, and C. Corrigan. 2005. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J. Immunol. 174: 8183-8190.
42. Kaur, D., C. Doe, L. Woodman, W. Y. Wan, A. Sutcliffe, F. Hollins, and C. Brightling. 2012. Mast cell-airway smooth muscle crosstalk: the role of thymic stromal lymphopoietin. Chest 142: 76-85.
43. Shikotra, A., D. F. Choy, C. M. Ohri, E. Doran, C. Butler, B. Hargadon, M. Shelley, A. R. Abbas, C. D. Austin, J. Jackman, L. C. Wu, L. G. Heaney, J. R. Arron, and P. Bradding. 2012. Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma. J. Allergy Clin. Immunol. 129: 104-111, e101-e109.
44. Ohle, S. J., A. Anandaiah, A. J. Fabian, A. Fine, and D. N. Kotton. 2012. Maintenance and repair of the lung endothelium does not involve contributions from marrow-derived endothelial precursor cells. Am. J. Respir. Cell Mol. Biol. 47: 11-19.
45. Taflin, C., B. Favier, J. Baudhuin, A. Savenay, P. Hemon, A. Bensussan, D. Charron, D. Glotz, and N. Mooney. 2011. Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions. Proc. Natl. Acad. Sci. USA 108: 2891-2896.
46. Schulte, D., V. Küppers, N. Dartsch, A. Broermann, H. Li, A. Zarbock, O. Kamenyeva, F. Kiefer, A. Khandoga, S. Massberg, and D. Vestweber. 2011. Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. EMBO J. 30: 4157-4170.
47. Saenz, S. A., M. C. Siracusa, J. G. Perrigoue, S. P. Spencer, J. F. Urban, Jr., J. E. Tocker, A. L. Budelsky, M. A. Kleinschek, R. A. Kastelein, T. Kambayashi, et al. 2010. IL25 elicits a multipotent progenitor cell population that promotes T (H)2 cytokine responses. Nature 464: 1362-1366.
48. Neill, D. R., S. H. Wong, A. Bellosi, R. J. Flynn, M. Daly, T. K. Langford, C. Bucks, C. M. Kane, P. G. Fallon, R. Pannell, et al. 2010. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464: 1367-1370.
49. Moro, K., T. Yamada, M. Tanabe, T. Takeuchi, T. Ikawa, H. Kawamoto, J. Furusawa, M. Ohtani, H. Fujii, and S. Koyasu. 2010. Innate production of T (H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463: 540-544.
50. Petersen, B. C., A. L. Budelsky, A. P. Baptist, M. A. Schaller, and N. W. Lukacs. 2012. Interleukin-25 induces type 2 cytokine production in a steroid-resistant interleukin-17RB+ myeloid population that exacerbates asthmatic pathology. Nat. Med. 18: 751-758.